Darren Hite serves as Partner, having joined the firm in 2006.
Darren focuses on investments addressing key inefficiencies in large healthcare markets, and his efforts have helped catapult Aberdare into a leadership position at the intersection of healthcare and the new wave of information technology. More recently, Darren has led Aberdare’s investment efforts in healthcare technology companies outside of the US.
Darren manages Aberdare’s commitments in companies that bring transparency and efficiency to clinical trial management (goBalto), consumer wellness (Jiff), and medication adherence (RxAnte) and he is the Director of Special Projects at mc10. He was a founding investor in Rock Health, the premier incubator for healthcare technology companies based in San Francisco and is a mentor for early stage healthcare technology companies through his involvement with Rock Health, Blueprint Health, UCSF, and Stanford.
Prior to Aberdare, Darren has spent his career in clinical medicine, finance, and entrepreneurship. He was a corporate strategy associate at Medtronic and an investment banking analyst and co-founder of the eHealth group at Robertson Stephens.
Darren attended the MD program at Georgetown University School of Medicine and the Biodesign program at Stanford University. He holds an AB in Evolutionary Biology from Princeton University and an MBA from the Stanford Graduate School of Business.